Physician profile
Alex Gitelman
NPI 1063692861
$157,590.79
in general payments reported to CMS, 2019-2025
26 companies · $19K in 2025
The $19K reported for 2025 was more than what 78% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $16K · 2021: $12K · 2022: $33K · 2023: $19K · 2024: $30K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Royalty Or License: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $3,465 · Food and Beverage: $1,847 · Gift: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,204.00 |
| Royalty Or License | $22,445.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $3,464.84 |
| Food and Beverage | $1,846.96 |
| Gift | $441.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $63,644.94 | 2019-2025 | Spinal, Raphael Pedicle Screw System |
| Stryker Corporation | $27,474.94 | 2019-2025 | N/A, Bio4, Yukon Oct Spinal System |
| Sanara Medtech INC. | $20,009.36 | 2020-2024 | Celleraterx |
| Life Spine, INC. | $12,052.16 | 2019-2022 | |
| The Institute of Musculoskeletal Science and Education | $11,106.89 | 2019-2025 | Spira |
| Zavation Medical Products, LLC | $6,400.00 | 2022 | |
| Expanding Innovations, INC. | $4,279.00 | 2024-2025 | X-Pac |
| Camber Spine Technologies LLC | $3,608.84 | 2019-2022 | |
| Precision Spine, INC. | $3,000.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $1,470.00 | 2023 | Seglentis |
| Surgalign Spine Technologies, INC. | $770.00 | 2019 | |
| Cerapedics INC. | $714.14 | 2020-2021 | |
| Ethicon INC. | $675.00 | 2020 | |
| Medtronic, INC. | $550.00 | 2022 | |
| Arteriocyte Medical Systems, INC. | $387.68 | 2024-2025 | Magellan |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $302.11 | 2025 | Tritanium Pl |
| Smith+Nephew, INC. | $270.06 | 2021-2025 | Real Intelligence, Aetos Shoulder System |
| Medtronic USA, INC. | $246.25 | 2019-2020 | |
| Si-Bone, INC. | $225.29 | 2020-2022 | |
| Wound Management Technologies, INC | $153.40 | 2019 | |
| Globus Medical, INC. | $87.67 | 2019 | |
| Orthofix Medical, INC. | $71.23 | 2019-2024 | Spinal-Stim, Spinal-Stim |
| Xtant Medical INC | $48.98 | 2024 | |
| Boston Scientific Corporation | $24.65 | 2023 | |
| Bioventus LLC | $18.20 | 2023 | Durolane |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$608,398.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Gitelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.